Variant report
Variant | nsv978897 |
---|---|
Chromosome Location | chr19:43137733-43151377 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:277)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr19:43149390..43151656-chr19:43158079..43159963,2 | MCF-7 | breast: | |
2 | chr19:43139185..43139985-chr19:43166999..43167914,2 | MCF-7 | breast: | |
3 | chr19:43139154..43139986-chr19:43246322..43246897,2 | MCF-7 | breast: | |
4 | chr19:43148558..43149434-chr20:53015100..53015659,2 | MCF-7 | breast: | |
5 | chr19:43138891..43139734-chr19:43166436..43166942,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
CEACAMP1 | TF binding region |
ENSG00000231561 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs190736657 | chr19:43137735-43137736 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs537122933 | chr19:43137762-43137763 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs557064490 | chr19:43137818-43137819 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs560328668 | chr19:43137824-43137825 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs182025045 | chr19:43137849-43137850 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs539651093 | chr19:43137896-43137897 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs553352546 | chr19:43137922-43137923 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs566273708 | chr19:43137985-43137986 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs573499164 | chr19:43138027-43138028 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs540642735 | chr19:43138028-43138029 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs560918536 | chr19:43138098-43138099 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs187237675 | chr19:43138230-43138231 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs574384015 | chr19:43138282-43138283 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs9304605 | chr19:43138308-43138309 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs563420399 | chr19:43138319-43138320 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs532298427 | chr19:43138358-43138359 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs189029683 | chr19:43138432-43138433 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs558083745 | chr19:43138449-43138450 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs559349393 | chr19:43138457-43138458 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs145092815 | chr19:43138483-43138484 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs112286253 | chr19:43138543-43138544 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs147567388 | chr19:43138556-43138557 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs542810971 | chr19:43138586-43138587 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs576454585 | chr19:43138594-43138595 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs77795375 | chr19:43138601-43138602 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs370936895 | chr19:43138735-43138736 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs181380941 | chr19:43138736-43138737 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs185519768 | chr19:43138886-43138887 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs539611462 | chr19:43138908-43138909 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs73932756 | chr19:43138975-43138976 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs543557878 | chr19:43139011-43139012 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs147752199 | chr19:43139028-43139029 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs190081311 | chr19:43139065-43139066 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs555827372 | chr19:43139078-43139079 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs182354542 | chr19:43139109-43139110 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs574481182 | chr19:43139172-43139173 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs543444824 | chr19:43139189-43139190 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs563331425 | chr19:43139228-43139229 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs377593312 | chr19:43139255-43139256 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs141095789 | chr19:43139260-43139261 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs545991143 | chr19:43139280-43139281 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs10402401 | chr19:43139284-43139285 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
43 | rs370751840 | chr19:43139320-43139321 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs548453034 | chr19:43139350-43139351 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs11669892 | chr19:43139352-43139353 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs530776563 | chr19:43139354-43139355 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs117317718 | chr19:43139357-43139358 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs570584826 | chr19:43139451-43139452 | Bivalent Enhancer Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs533232825 | chr19:43139511-43139512 | Bivalent Enhancer Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs10404509 | chr19:43139521-43139522 | Bivalent Enhancer Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Myelodysplastic syndrome | 17634407 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Cancer | 20164919 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Prostate cancer | 18632612 | CNVD |
Autism | 22495311 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Congenital nephrotic syndrome | 18421352 | CNVD |
Astrocytoma | 17934521 | CNVD |
Leukemia | 17361228 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
renal disease | 20603712 | CNVD |
Salivary gland adenoid cystic carcinoma | 17545515 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 21364760 | CNVD |
Invasive pancreatic ductal carcinoma | 18765526 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
Chordoma | 18071362 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Bladder cancer | 21909424 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Gastric cancer | 18160780 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Breast cancer | 20409316 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Astrocytoma | 22246337 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21509527 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr19:43137000-43139000 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
2 | chr19:43139000-43139600 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
3 | chr19:43139400-43139600 | Bivalent Enhancer | IMR90 fetal lung fibroblasts Cell Line | lung |
4 | chr19:43150400-43150600 | ZNF genes & repeats | Brain Hippocampus Middle | brain |
5 | chr19:43150600-43159800 | Weak transcription | Brain Hippocampus Middle | brain |